ArticlePLoS computational biology2011

An integrated disease/pharmacokinetic/pharmacodynamic model suggests improved interleukin-21 regimens validated prospectively for mouse solid cancers.

Moran Elishmereni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.